First Patient Dosed in Phase I/II Study of Experimental Gene Therapy for Cystinosis
According to a recent press release from the Massachusetts-based biotechnology company Avrobio, Inc., the first patient has been dosed in the Company's phase I/II clinical study of their investigational cystinosis…